Financials AmeriCann, Inc.

Equities

ACAN

US0305881072

Healthcare Facilities & Services

Market Closed - OTC Markets 02:01:53 2024-04-26 pm EDT 5-day change 1st Jan Change
0.061 USD 0.00% Intraday chart for AmeriCann, Inc. -6.44% -28.24%

Valuation

Fiscal Period: September 2018 2019 2020 2021 2022 2023
Capitalization 1 63.87 22.24 11.05 19.36 6.854 8.049
Enterprise Value (EV) 1 65.98 27.03 19.42 27.86 14.81 16.21
P/E ratio -13.8 x -4.45 x -15.6 x -20 x -28.1 x -85 x
Yield - - - - - -
Capitalization / Revenue - 1,923,173,729 x 21,940,420 x 9,542,303 x 2,341,040 x 3,153,886 x
EV / Revenue - 2,337,666,984 x 38,574,296 x 13,734,492 x 5,058,436 x 6,352,394 x
EV / EBITDA -32.7 x -7.97 x 74.6 x 56.3 x 15.9 x 15.2 x
EV / FCF -13 x -5.97 x 18.1 x -546 x 50.2 x 49.7 x
FCF Yield -7.69% -16.8% 5.53% -0.18% 1.99% 2.01%
Price to Book 9.84 x 3.65 x 1.9 x 3.51 x 1.18 x 1.41 x
Nbr of stocks (in thousands) 21,010 23,410 23,505 24,196 24,392 24,392
Reference price 2 3.040 0.9500 0.4700 0.8000 0.2810 0.3300
Announcement Date 1/15/19 1/14/20 12/21/20 12/6/21 12/29/22 12/22/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: September 2018 2019 2020 2021 2022 2023
Net sales - 0.0116 0.5035 2.029 2.928 2.552
EBITDA 1 -2.016 -3.391 0.2603 0.4948 0.9326 1.068
EBIT 1 -2.029 -3.392 -0.1866 0.0443 0.4827 0.6117
Operating Margin - -29,332.81% -37.05% 2.18% 16.49% 23.97%
Earnings before Tax (EBT) 1 -4.433 -4.904 -0.7093 -0.8629 -0.1732 -0.0948
Net income 1 -4.433 -4.904 -0.7093 -0.8629 -0.1732 -0.0948
Net margin - -42,404.6% -140.88% -42.54% -5.92% -3.71%
EPS 2 -0.2209 -0.2133 -0.0302 -0.0400 -0.009999 -0.003884
Free Cash Flow 1 -5.074 -4.528 1.074 -0.051 0.2948 0.3264
FCF margin - -39,158.76% 213.35% -2.51% 10.07% 12.79%
FCF Conversion (EBITDA) - - 412.69% - 31.61% 30.58%
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 1/15/19 1/14/20 12/21/20 12/6/21 12/29/22 12/22/23
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: Settembre 2018 2019 2020 2021 2022 2023
Net Debt 1 2.11 4.79 8.38 8.5 7.96 8.16
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) -1.045 x -1.414 x 32.18 x 17.19 x 8.531 x 7.647 x
Free Cash Flow 1 -5.07 -4.53 1.07 -0.05 0.29 0.33
ROE (net income / shareholders' equity) -97.3% -75.8% -11.8% -15.2% -3.06% -1.65%
ROA (Net income/ Total Assets) -16.3% -20% -0.88% 0.18% 1.98% 2.5%
Assets 1 27.12 24.55 81.02 -466.7 -8.758 -3.791
Book Value Per Share 2 0.3100 0.2600 0.2500 0.2300 0.2400 0.2300
Cash Flow per Share 2 0.0100 0.0200 0.0100 0.0300 0.0500 0.0500
Capex 1 0.7 5.89 0.39 0.09 0.25 0.28
Capex / Sales - 50,932.15% 76.76% 4.6% 8.39% 10.94%
Announcement Date 1/15/19 1/14/20 12/21/20 12/6/21 12/29/22 12/22/23
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. ACAN Stock
  4. Financials AmeriCann, Inc.